# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-13-052742
Filing Date
2013-09-27
Accepted
2013-09-27 14:30:42
Documents
26
Period of Report
2013-09-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | v355956_8k.htm | 8-K | 14925
2 | PRESENTATION | v355956_ex99-1.htm | EX-99.1 | 24686
3 | GRAPHIC | image_001.jpg | GRAPHIC | 24347
4 | GRAPHIC | image_002.jpg | GRAPHIC | 117894
5 | GRAPHIC | image_003.jpg | GRAPHIC | 73723
6 | GRAPHIC | image_004.jpg | GRAPHIC | 65130
7 | GRAPHIC | image_005.jpg | GRAPHIC | 89122
8 | GRAPHIC | image_006.jpg | GRAPHIC | 55736
9 | GRAPHIC | image_007.jpg | GRAPHIC | 41540
10 | GRAPHIC | image_008.jpg | GRAPHIC | 67135
11 | GRAPHIC | image_009.jpg | GRAPHIC | 77441
12 | GRAPHIC | image_010.jpg | GRAPHIC | 64320
13 | GRAPHIC | image_011.jpg | GRAPHIC | 63284
14 | GRAPHIC | image_012.jpg | GRAPHIC | 25863
15 | GRAPHIC | image_013.jpg | GRAPHIC | 45847
16 | GRAPHIC | image_014.jpg | GRAPHIC | 63832
17 | GRAPHIC | image_015.jpg | GRAPHIC | 61750
18 | GRAPHIC | image_016.jpg | GRAPHIC | 51643
19 | GRAPHIC | image_017.jpg | GRAPHIC | 58992
20 | GRAPHIC | image_018.jpg | GRAPHIC | 59301
21 | GRAPHIC | image_019.jpg | GRAPHIC | 71318
22 | GRAPHIC | image_020.jpg | GRAPHIC | 65929
23 | GRAPHIC | image_021.jpg | GRAPHIC | 76674
24 | GRAPHIC | image_022.jpg | GRAPHIC | 55109
25 | GRAPHIC | image_023.jpg | GRAPHIC | 61270
26 | GRAPHIC | image_024.jpg | GRAPHIC | 21992
| Complete submission text file | 0001144204-13-052742.txt |  | 2054838

Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 131119419
SIC: 2834 Pharmaceutical Preparations